NOX 4.17% 6.9¢ noxopharm limited

Ann: DARRT-2 Study Update and Clarification, page-17

  1. 425 Posts.
    lightbulb Created with Sketch. 206
    Old news there Harvett. I'd always been impressed GK didn't harp on about it during webinars or presentations and let trial data do the talking. It'd be an easy story to keep repeating for potential investors. Wonder if ABR approached NOX or vice versa. Interesting narrative anyway.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.